BioSpace News Archive

BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), (the “Company” or “Bioasis”), today announced that following the formal annual general meeting (“AGM”) proceedings, the Company will host a webcast presentation and conference call, currently scheduled for 09:15 am EST, Thursday, December 5, 2019.

GENOMICA, the molecular diagnostics company belonging to the PharmaMar Group (MSE:PHM), begins to materialize its first contract in China with the medical equipment company, HuaSin Science, to lead the global challenge of the early diagnosis of cervical cancer in China.

Appili Therapeutics Inc., a biopharmaceutical company focused on anti-infective drug development, reported its financial and operational results for the second quarter of its fiscal year 2020, ending September 30, 2019.

Revive Therapeutics Ltd., a specialty cannabis company focused on the research, development, and commercialization of novel cannabinoid-based products, announced its results for the three months ended September 30, 2019.

Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, announced the completion of a US$ 43 million Series B financing.

Innovent Biologics, Inc. jointly announced with Eli Lilly and Company that the innovative PD-1 inhibitor Tyvyt®, co-developed by both companies, is the only PD-1 inhibitor that has been included in the new Catalogue of National Reimbursement Drug List according to the latest announcement from the National Healthcare Security Administration.

ImmersiveView 3.0™ aims to help interventional radiologists perform with greater speed and precision

This event will feature presentations from KOLs George Ansstas, MD, Washington University of Medicine in St. Louis, Chaitali Nangia, MD, Chan Soon-Shiong Institute for Medicine, and Clint Allen, MD, Johns Hopkins Kimmel Cancer Center, as well as Dr. Patrick Soon-Shiong, Chief Executive Officer and Chairman of NantKwest.

Each presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investors.hologic.com.

Introducing A Series of Upgraded AI Solutions: VUNO Med®-BoneAge, VUNO Med®-DeepBrain, VUNO Med®-Chest X-ray, and VUNO Med®-LungCT AI